Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Feldman

Showing results (101-110 of 1,291) with videos related to

Pageof 130
Sort By:
Pediatric Dermatology|January 10, 2018
Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroidsDaniel J Lewis, Steven R Feldman
Journal of Drugs in Dermatology : JDD|January 5, 2021
Ingenol Mebutate and the Treatment of Actinic KeratosisCourtney E Heron, Steven R Feldman
Dermatologic Clinics|March 4, 2009
Dermatologic medication adherenceBridgit V Nolan, Steven R Feldman
The Journal of Dermatological Treatment|March 20, 2020
Should patients stop their biologic treatment during the COVID-19 pandemicArjun M Bashyam, Steven R Feldman
Journal of the American Academy of Dermatology|March 16, 2020
Steroid phobia isn't reduced by improving patients' knowledge of topical corticosteroidsSteven R Feldman, William W Huang
Journal of the American Academy of Dermatology|June 17, 2017
Comorbidities in patients with psoriasis: The role of the dermatologistMohammed D Saleem, Steven R Feldman
Journal of the American Academy of Dermatology|August 21, 2016
The proliferation of online for-profit medical journalsWilliam W Huang, Steven R Feldman
The Journal of Dermatological Treatment|June 8, 2010
Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the icebergBrad A Yentzer, Steven R Feldman
The Journal of Dermatological Treatment|October 28, 2017
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?Kevin K Veverka, Steven R Feldman
Journal of the American Academy of Dermatology|October 12, 2024
Response to deucravacitinib in psoriasis patients with prior biologic therapy failures: A retrospective studyKatie K Lovell, Steven R Feldman
Pageof 130

Showing results (101-110 of 1,291) with videos related to

Sort By:
Pageof 130
Pediatric Dermatology|January 10, 2018
Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroidsDaniel J Lewis, Steven R Feldman
Journal of Drugs in Dermatology : JDD|January 5, 2021
Ingenol Mebutate and the Treatment of Actinic KeratosisCourtney E Heron, Steven R Feldman
Dermatologic Clinics|March 4, 2009
Dermatologic medication adherenceBridgit V Nolan, Steven R Feldman
The Journal of Dermatological Treatment|March 20, 2020
Should patients stop their biologic treatment during the COVID-19 pandemicArjun M Bashyam, Steven R Feldman
Journal of the American Academy of Dermatology|March 16, 2020
Steroid phobia isn't reduced by improving patients' knowledge of topical corticosteroidsSteven R Feldman, William W Huang
Journal of the American Academy of Dermatology|June 17, 2017
Comorbidities in patients with psoriasis: The role of the dermatologistMohammed D Saleem, Steven R Feldman
Journal of the American Academy of Dermatology|August 21, 2016
The proliferation of online for-profit medical journalsWilliam W Huang, Steven R Feldman
The Journal of Dermatological Treatment|June 8, 2010
Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the icebergBrad A Yentzer, Steven R Feldman
The Journal of Dermatological Treatment|October 28, 2017
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?Kevin K Veverka, Steven R Feldman
Journal of the American Academy of Dermatology|October 12, 2024
Response to deucravacitinib in psoriasis patients with prior biologic therapy failures: A retrospective studyKatie K Lovell, Steven R Feldman
Pageof 130